Aurora Cannabis Inc (ACB) reports significant revenue increases and maintains a robust cash position, despite challenges in ...

ACB EDMONTON, AB, Aug. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a ...

Despite reporting better-than-expected revenue for Q1 fiscal 2026, Aurora Cannabis (NASDAQ:ACB) traded ~9% lower after the ...

Aurora Cannabis ( ($TSE:ACB) ) has issued an announcement. Aurora Cannabis Inc. announced the results of its 2025 Annual General and Special ...

Greetings and welcome to Aurora Cannabis Incorporated Fiscal First Quarter 2026 Results Conference Call all participants will ...

We recently compiled a list of the 12 Cheap Pot Stocks to Buy According to Hedge Funds. Aurora Cannabis Inc. stands fourth on ...

Aurora Cannabis Inc. shares T.ACB are trading down $0.37 at $5.97.

Aurora said it anticipates revenue will increase year over year in the second fiscal quarter, supported by between 8% and 12% growth in its global medical cannabis segment. Plant propagation revenue ...

Last quarter, Aurora Cannabis reported just a 5% increase in its top line, compared to the prior-year period, with sales climbing to CA$67.4 million.

Aurora Cannabis Inc. closed 37.78% short of its 52-week high of $7.20, which the company reached on August 15th.

Medical-cannabis net revenue in the most recent quarter, which ended on Sept. 30, totaled 43.8 million Canadian dollars ($32.3 million), which was nearly four times Aurora's consumer-cannabis net ...

Aurora Cannabis (ACB 1.89%) has perhaps been the most disappointing pot stock since Canada legalized adult recreational uses of marijuana back in 2018 -- and that's saying something.